If Pfizer’s coronavirus vaccine gets approved, there are still significant challenges when it comes to mass-production and distribution. Ted Chernecki reports
- Airlines scramble to prepare for ultra-cold shipping of coronavirus vaccine
- No coronavirus vaccine, no entry? Experts say it’s possible in pandemic’s next stage
- Nova Scotia reports no new COVID-19 cases on Thursday